Almeling R (June 2007). "Selling genes, selling gender: Egg agencies, sperm banks, and the medical market in genetic material". American Sociological Review. 72 (3): 319–40. doi:10.1177/000312240707200301. S2CID59570455.
Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O (January 2009). "Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial". Gynecological Endocrinology. 25 (1): 60–6. doi:10.1080/09513590802404013. PMID19165664. S2CID5993269.
Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (February 2009). "Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study". Fertility and Sterility. 91 (2): 365–71. doi:10.1016/j.fertnstert.2007.11.049. PMID18367175.
"Donation and the Law". Malvern, Worcestershire, UK: National Gamete Donation Trust (NGDT). Archived from the original on 5 November 2014. Retrieved 5 November 2014.
Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O (January 2009). "Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial". Gynecological Endocrinology. 25 (1): 60–6. doi:10.1080/09513590802404013. PMID19165664. S2CID5993269.
Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (February 2009). "Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study". Fertility and Sterility. 91 (2): 365–71. doi:10.1016/j.fertnstert.2007.11.049. PMID18367175.
Salhab M, Al Sarakbi W, Mokbel K (November 2005). "In vitro fertilization and breast cancer risk: a review". International Journal of Fertility and Women's Medicine. 50 (6): 259–66. PMID16526416.
Almeling R (June 2007). "Selling genes, selling gender: Egg agencies, sperm banks, and the medical market in genetic material". American Sociological Review. 72 (3): 319–40. doi:10.1177/000312240707200301. S2CID59570455.
Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O (January 2009). "Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial". Gynecological Endocrinology. 25 (1): 60–6. doi:10.1080/09513590802404013. PMID19165664. S2CID5993269.
"Donation and the Law". Malvern, Worcestershire, UK: National Gamete Donation Trust (NGDT). Archived from the original on 5 November 2014. Retrieved 5 November 2014.